MARITIDE
"MARITIDE" is a trademark owned by Amgen Inc., filed at the WIPO on May 7, 2026. It is on file and covers class 5 (Pharmaceuticals).
- Status
- Mixed
- Filed
- May 7, 2026
- Registered
- Not yet
- Expires
- May 7, 2036
- Application no.
- Not recorded
- Registration no.
- 1920840
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 1 class
Who owns MARITIDE
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Amgen Inc.
AMGN · United States
Representative
Elsa D. Lemoine Amgen Inc.
What the mark covers
The products and services MARITIDE is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders, and obesity; pharmaceutical preparations for weight reduction and long-term weight loss maintenance.
About MARITIDE
Who owns the trademark "MARITIDE"?
The WIPO trademark "MARITIDE" is owned by Amgen Inc.
What is the status of "MARITIDE"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull MARITIDE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_e3ba9e81-6c63-4538-b7be-57473e29f48c
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_e3ba9e81-6c63-4538-b7be-57473e29f48c",
"object": "trademark",
"mark_text": "MARITIDE",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2026-05-07",
"nice_classes": [
5
],
"owners": [
{
"name": "Amgen Inc.",
"entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
}
]
}